
    
      New users of the LNG IUD will be eligible. Subjects will be randomized to receive tamoxifen
      10 mg twice daily for 7 days or placebo. Study drug will be started 3 weeks after placement
      of the IUD. Subjects will maintain a record of daily bleeding and spotting using an
      electronic text messaging diary.
    
  